Literature DB >> 305461

Autologous leukemia-specific T-cell-mediated lymphocytotoxicity in patients with acute myelogenous leukemia.

S K Lee, R T Oliver.   

Abstract

Short-term culture of acute myelogenous leukemia patient's remission lymphocytes with inactivated autologous leukemic blast cells plus allogeneic lymphocytes, generated effector T lymphocytes which were cytotoxic for the specific autologous blast cell in 11 of 14 patients studied. Experiments using Daudi and Molt 4 lymphoblastoid cell lines as third-party helper cell suggest that an HLA D locus incompatability is necessary to provide effective help in this system. Cold target inhibition experiments, crossover studies between pairs of patients, and experiments with allogeneic leukemic blast cells as priming stimulus suggest that the target antigen is only present on the specific autologous blast cell.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 305461      PMCID: PMC2184196          DOI: 10.1084/jem.147.3.912

Source DB:  PubMed          Journal:  J Exp Med        ISSN: 0022-1007            Impact factor:   14.307


  24 in total

1.  Study of human T and B lymphocytes with heterologous antisera. I Preparation, specificity and properties of antisera.

Authors:  J Brochier; Y A Abou-Hamed; J P Gueho; J P Revillard
Journal:  Immunology       Date:  1976-11       Impact factor: 7.397

Review 2.  IMMUNOLOGY OF EXPERIMENTAL TUMORS.

Authors:  L J OLD; E A BOYSE
Journal:  Annu Rev Med       Date:  1964       Impact factor: 13.739

3.  The specificty and the activation mechanism of cell-mediated lympholysis (CML) in man.

Authors:  V P Eijsvoogel; M J du Bois; A Meinesz; A Bierhorst-Eijlander; W P Zeylemaker; P T Schellekens
Journal:  Transplant Proc       Date:  1973-12       Impact factor: 1.066

4.  Lymphocyte activation and destruction in vitro in relation to MLC and HL-A.

Authors:  V P Eijsvoogel; R du Bois; C J Melief; W P Zeylemaker; L Raat-Koning; L de Groot-Kooy
Journal:  Transplant Proc       Date:  1973-09       Impact factor: 1.066

5.  Studies on specificity of cell-mediated immunity to human tumors.

Authors:  M Takasugi; M R Mickey; P I Terasaki
Journal:  J Natl Cancer Inst       Date:  1974-12       Impact factor: 13.506

6.  Cell-mediated destruction of human leukemic cells by MHC identical lymphocytes: requirement for a proliferative trigger in vitro.

Authors:  P M Sondel; C O'Brien; L Porter; S F Schlossman; L Chess
Journal:  J Immunol       Date:  1976-12       Impact factor: 5.422

7.  Eighty years of immunotherapy: a review of immunological methods used for the treatment of human cancer.

Authors:  G A Currie
Journal:  Br J Cancer       Date:  1972-06       Impact factor: 7.640

8.  Immunotherapy for acute myelogenous leukaemia: a controlled clinical study 2 1/2 years after entry of the last patient.

Authors:  R L Powles; J Russell; T A Lister; T Oliver; J M Whitehouse; J Malpas; B Chapuis; D Crowther; P Alexander
Journal:  Br J Cancer       Date:  1977-03       Impact factor: 7.640

9.  Radiation leukemia in C57BL/6 mice. I. Lack of serological evidence for the role of endogenous ecotropic viruses in pathogenesis.

Authors:  J N Ihle; R McEwan; K Bengali
Journal:  J Exp Med       Date:  1976-12-01       Impact factor: 14.307

10.  Radiation leukemia in C57BL/6 mice. II. Lack of ecotropic virus expression in the majority of lymphomas.

Authors:  J N Ihle; D R Joseph; N H Pazmino
Journal:  J Exp Med       Date:  1976-12-01       Impact factor: 14.307

View more
  23 in total

1.  Mitogenic stimulation of human tumor-infiltrating lymphocytes by secreted factor(s) from human tumor cell lines.

Authors:  B S Packard
Journal:  Proc Natl Acad Sci U S A       Date:  1990-06       Impact factor: 11.205

2.  HL-60 myeloid leukaemia cells acquire immunostimulatory capability upon treatment with retinoic acid: analysis of the responding population and mechanism of cytotoxic lymphocyte activation.

Authors:  S M Geary; L K Ashman
Journal:  Immunology       Date:  1996-07       Impact factor: 7.397

Review 3.  Specific adoptive immunotherapy: experimental basis and future potential.

Authors:  P D Greenberg; M A Cheever; A Fefer
Journal:  Surv Immunol Res       Date:  1982

4.  In vitro generation of effector cells cytotoxic to autologous targets from chronic myeloid leukemia patients in remission.

Authors:  R Somasundaram; S G Rao; S H Advani; S G Gangal
Journal:  Cancer Immunol Immunother       Date:  1988       Impact factor: 6.968

5.  Adjuvant immune stimulation with Corynebacterium parvum during maintenance chemotherapy of acute myeloid leukemia. A prospective randomized study.

Authors:  E la Cour Petersen; P Hokland; J Ellegaard
Journal:  Cancer Immunol Immunother       Date:  1983       Impact factor: 6.968

6.  The role of allogeneic cells in the stimulation of cell-mediated cytotoxicity to leukaemia cells. A family study.

Authors:  G M Taylor; B A Bradley
Journal:  Cancer Immunol Immunother       Date:  1983       Impact factor: 6.968

7.  Deficient expression of class-I HLA in some cases of acute leukemia.

Authors:  W L Elkins; A Pickard; G R Pierson
Journal:  Cancer Immunol Immunother       Date:  1984       Impact factor: 6.968

8.  In vitro elicitation of cytotoxic response against a nonimmunogenic murine tumor by allosensitization.

Authors:  B Leshem; B Gotsman; E Kedar
Journal:  Cancer Immunol Immunother       Date:  1984       Impact factor: 6.968

9.  Effect of neuraminidase treatment on serum reactivity to autologous leukemic blast cells.

Authors:  M Pfreundschuh; B Dörken; W Brandeis; W Hunstein; P Wernet
Journal:  Cancer Immunol Immunother       Date:  1983       Impact factor: 6.968

10.  Cell-mediated immune responses between HLA-identical siblings: recognition of antigenic changes associated with acute myelogenous leukaemia.

Authors:  K S Zier; C Huber; E Albert; H Braunsteiner
Journal:  Clin Exp Immunol       Date:  1980-04       Impact factor: 4.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.